Anteris Technologies Global Corp. (AVR): Cost of Revenue
$569.0K
Year ended 2025-12-31
$564.0K
Trailing 12 months to 2026-09-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $569.0K | -60.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $1.44M | n/a | 2026-02-26, From 2024-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Anteris Technologies Global Corp. (AVR) | 2025-12-31 | $569.0K | -60.4% |
| NutriBand Inc. (NTRB) | 2026-01-31 | $1.47M | +5.3% |
| CollPlant Biotechnologies Ltd (OPHI) | 2025-12-31 | $835.0K | -48.6% |
| ENvue Medical, Inc. (FEED) | 2025-12-31 | $2.40M | +128.6% |
| Milestone Scientific Inc. (MLSS) | 2025-12-31 | $2.57M | +16.9% |
| Envoy Medical, Inc. (COCH) | 2025-12-31 | $874.0K | +17.8% |
| Jin Medical International Ltd. (ZJYL) | 2025-09-30 | $14.64M | +4.6% |
| Lifeward Ltd. (LFWD) | 2025-12-31 | $13.61M | -22.0% |
| Myomo, Inc. (MYO) | 2025-12-31 | $14.04M | +49.9% |
Compare AVR, NTRB, OPHI, FEED side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗